MENU
RDY
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Dr. Reddy's Laboratories (RDY) Ownership - Who owns Dr. Reddy's Laboratories?
Dr... Show more
Industry: #Pharmaceuticals Generic
Profile
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
11.91B
P/E Ratio
18.63
Total Cash
66.69B
Projected Growth
3.20
Total Debt
48.64B
Revenue
334.26B
Risk (Beta)
0.53
Dividend Yield
0.01
Total Cash/Share
80.10
Total Debt/Equity
49.28
Revenue/Share
4.56 USD as % of share price
Fundamentals
RDY
Capitalization
11.9B
P/E Ratio
18.63
Risk (Beta)
0.53
Dividend Yield
0.01
Total Cash
66.7B
Total Cash/Share
80.10
Total Debt
48.6B
Total Debt/Equity
49.28
Projected Growth (PEG Ratio)
3.20
Revenue/Share (as % of the share price)
4.56%
Revenue
334B
ROE
N/A
Book Value
350B
P/B Ratio
3.02
Cash Flow
N/A
Earnings
68.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
835M
Current Ratio
1.89
Current Revenue Per Employee
3072597.20
Dividends Per Share - Security
0.00
EBITDA
98.1B
Float
N/A
Float - Current
N/A
Gross Income Margin
56.91
Revenue To Assets
10.93
Shares Held By Institutions
2.79B
Shares Outstanding - Current
833M
Total Liabilities
166B
Total Volume MTD
N/A
Value
-1
Gain YTD
-9.379
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RDY showed earnings on July 23, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com